These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7955222)

  • 1. Acute magnesium administration and frequency of ventricular arrhythmia in heart failure.
    Bradding P; Withers N
    Circulation; 1994 Nov; 90(5):2566. PubMed ID: 7955222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Magnesium in congestive heart failure].
    Ohtsuka S; Yamaguchi I
    Clin Calcium; 2005 Feb; 15(2):181-6. PubMed ID: 15692155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnesium metabolism in heart failure (author's transl)].
    Sato T
    Kokyu To Junkan; 1976 May; 24(5):389-93. PubMed ID: 818691
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
    Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
    Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
    Gao X; Peng L; Adhikari CM; Lin J; Zuo Z
    J Card Fail; 2007 Apr; 13(3):170-7. PubMed ID: 17448413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digoxin in chronic heart failure and sinus rhythm: is the end of the controversy in sight?].
    van Veldhuisen DJ; de Graeff PA; Crijns HJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(10):460-4. PubMed ID: 9173285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between blood serum magnesium and potassium levels in patients with right-ventricular circulatory insufficiency treated with lanatoside C, and the role of magnesium in the prevention of digitalis-induced arrhythmias].
    Smołuch R
    Pol Tyg Lek; 1980 Nov; 35(45):1737-9. PubMed ID: 7220373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Simultaneous increase of drug effect on the heart and tolerance of digoxin by combination of electrolytes, flavones and purines].
    Jaursch U; Lander E; Schmidt R; Schmoldt H; Simon KH
    Med Welt; 1969 Jul; 27():1547-52. PubMed ID: 5816435
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure.
    Sueta CA; Clarke SW; Dunlap SH; Jensen L; Blauwet MB; Koch G; Patterson JH; Adams KF
    Circulation; 1994 Feb; 89(2):660-6. PubMed ID: 7508827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [You and digoxin].
    Laflamme M; Leclerc L; Lemieux B
    Infirm Can; 1985 Nov; 27(10):28-30. PubMed ID: 3854003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of magnesium in cardiac arrhythmias].
    Stühlinger HG; Kiss K; Smetana R
    Wien Med Wochenschr; 2000; 150(15-16):330-4. PubMed ID: 11105328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin in patients with heart failure.
    Böhm M
    N Engl J Med; 1997 Jul; 337(2):129-30; author reply 130-1. PubMed ID: 9221339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of beta-methyldigoxin (Lanitop)].
    Ostrowski K; Tracz P
    Pol Tyg Lek; 1974 Aug; 29(32):1395-7. PubMed ID: 4848295
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of magnesium in the management of cardiopathy].
    Ramos RA; Vieira SR; Ribeiro JP
    Arq Bras Cardiol; 1995 Nov; 65(5):431-5. PubMed ID: 8729862
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypomagnesemia in relation to digoxin intoxication in children.
    Singh RB; Dube KP; Srivastav PK
    Am Heart J; 1976 Aug; 92(2):144-7. PubMed ID: 941825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin for the treatment of chronic and acute heart failure syndromes.
    Gheorghiade M; Harinstein ME; Filippatos GS
    Acute Card Care; 2009; 11(2):83-7. PubMed ID: 19384675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium and magnesium depletions in congestive heart failure--pathophysiology, consequences and replenishment.
    Iezhitsa IN
    Clin Calcium; 2005 Nov; 15(11):123-33. PubMed ID: 16272623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.